Palak R. Parekh

Recent developments in the use of γ -H2AX as a quantitative DNA double-strand break biomarker

Christophe E. Redon, Asako Nakamura, Olga A. Martin et al. · Aging · 2011 · 169 citations · Full text

Pharmacy, Cancer Biology, Molecular Biology +17

Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells

Palak R. Parekh, Leena Motiwale, Nishigandha Naik et al. · Experimental and Toxicologic Pathology · 2010 · 87 citations

Medicine, Cancer Biology, Oncology +10

The histone variant H2A.X is a regulator of the epithelial–mesenchymal transition

Urbain Weyemi, Christophe E. Redon, Rohini Choudhuri et al. · Nature Communications · 2016 · 82 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Inactivation of NADPH Oxidases NOX4 and NOX5 Protects Human Primary Fibroblasts from Ionizing Radiation-Induced DNA Damage

Urbain Weyemi, Christophe E. Redon, Towqir Aziz et al. · Radiation Research · 2015 · 75 citations · Full text

Dentistry, Molecular Biology, Oncology +17

Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model

Jennifer S. Dickey, Yanira González, Baikuntha Aryal et al. · PLoS ONE · 2013 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17